Although diabetes only occurred following anti–PD-L1 treatment, both anti–PD-L1–treated NOD mice and anti–CTLA-4–treated NOD mice developed immune infiltrates (Supplemental Figure 2, A–C), indicating that differences in the immune and/or β cells account for the susceptibility to diabetes. Here, CTLA4 is linked to diabetes mellitus.